Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.51 - $17.1 $10,863 - $364,230
-21,300 Reduced 23.23%
70,400 $49,000
Q3 2022

Nov 14, 2022

BUY
$1.01 - $17.0 $4,444 - $74,800
4,400 Added 5.04%
91,700 $139,000
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $197,262 - $515,072
-365,300 Reduced 80.71%
87,300 $87,000
Q1 2022

May 16, 2022

BUY
$1.4 - $5.15 $123,199 - $453,200
88,000 Added 24.14%
452,600 $652,000
Q4 2021

Feb 14, 2022

BUY
$4.27 - $6.97 $1.32 Million - $2.16 Million
310,200 Added 570.22%
364,600 $1.9 Million
Q3 2021

Nov 15, 2021

SELL
$5.31 - $8.25 $253,817 - $394,350
-47,800 Reduced 46.77%
54,400 $317,000
Q2 2021

Aug 16, 2021

SELL
$6.81 - $9.23 $213,153 - $288,899
-31,300 Reduced 23.45%
102,200 $824,000
Q1 2021

May 17, 2021

BUY
$7.99 - $15.0 $95,081 - $178,500
11,900 Added 9.79%
133,500 $1.11 Million
Q4 2020

Feb 16, 2021

BUY
$7.04 - $11.7 $668,800 - $1.11 Million
95,000 Added 357.14%
121,600 $922,000
Q3 2020

Nov 16, 2020

SELL
$9.98 - $18.04 $737,522 - $1.33 Million
-73,900 Reduced 73.53%
26,600 $284,000
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $366,261 - $741,324
48,900 Added 94.77%
100,500 $1.52 Million
Q1 2020

May 15, 2020

BUY
$4.62 - $18.74 $163,086 - $661,522
35,300 Added 216.56%
51,600 $430,000
Q4 2019

Feb 14, 2020

BUY
$14.6 - $18.13 $237,980 - $295,519
16,300 New
16,300 $275,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.